Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2).

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study was designed to test the hypothesis of whether amlodipine reduces the risk for death in patients with heart failure due to a nonischemic cardiomyopathy.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): JACC Heart Fail

Title: JACC. Heart failure

ISSN (Electronic): 2213-1787

ISSN (Print): 2213-1779

Publication date (Electronic): Aug 2013

Volume: 1

Issue: 4

Affiliations

[1 ] Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: Milton.Packer@UTSouthwestern.edu.

[2 ] Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.

Article

Publisher Item ID: S2213-1779(13)00184-4

DOI: 10.1016/j.jchf.2013.04.004

PubMed ID: 24621933

SO-VID: 07bd247a-8c30-48e8-bf43-68c1693f853c

History

Keywords: amlodipine,clinical trials,heart failure,nonischemic cardiomyopathy

Data availability:

Keywords: amlodipine, clinical trials, heart failure, nonischemic cardiomyopathy

Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2).

Read this article at

Abstract

Related collections

Drug Repurposing

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 23